Search Results For :: patient flow
-
Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030
The medical membranes market is expected to grow from USD 4.31 billion in 2025 to USD 6.66 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period. The Key Players Asahi Kasei Corporation (Japan), Mann+Hummel (Germany), Sartorius AG (Germany), Merck KGaA (Germany), Solventum (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Kovalus Separation Solutions (US), and Cobetter (China).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Medical Devices Market Size by Type (In Vitro Diagnostic Devices, Cardiovascular, Imaging, Ophthalmology, Endoscopy, Orthopedic, Diabetes Care, Wound Care Devices, Kidney/Dialysis Devices, Respiratory Care), Region - Global Forecast to 2031
The global medical devices market is projected to reach USD 817.78 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 8150
- TOC Available:
-
Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) & Region - Global Forecast to 2025
The global nuclear imaging equipment market growth is primed to transition from $2.6 billion in 2020 to $3.4 billion by 2025, showcasing a strong CAGR of 7.4%. The growth in this market is mainly driven by the the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
MRI Systems Market by Architecture (Open, Closed), Design (Portable, Fixed), Field Strength (1.5T, 3T, Low & Mid-field), Application (Neuro, Spine, Cardiac, Pediatric), End User (Hospital, Imaging Center, ASC), and Procedure Volume - Global Forecast to 2031
The global MRI systems market is projected to reach USD 9.68 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Drug Device Combination – (2009 - 2014)
This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications.
- Published: November 2009
- Price: $ 4950
- TOC Available:
-
Dental Equipment Market (2009 - 2014)
The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Medical Imaging - Global Displays and Post-Processing Software Market (2009 -2014)
Rising healthcare costs and the increasing demand for healthcare services have effected a significant transformation in the field of healthcare image management software over the last decade. Healthcare equipment vendors are now seeking to provide an integrated diagnostic model facilitating patient-centric, evidence-based healthcare. The major features of post-processing include workflow tasks such as image processing, image reconstruction, computer-aided detection, three-dimensional (3D) view generation, and quality control.
- Published: February 2010
- Price: $ 4950
- TOC Available:
-
IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Global Forecast to 2022
The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China
The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.
- Published: April 2010
- Price: $ 4950
- TOC Available:
Records 51 to 60 of 60
